RxDoctor Payments Data

Kathleen Hogan, MD

Adult Reconstructive Orthopaedic Surgery · Nashua, NHNPI 1316028970

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.2% of the total across 129 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Stryker at 37.3% of the total.

$5,421in general payments, 2019–2025

Across 129 payments — averaging $42.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Ferring Pharmaceuticals Inc.$537
  • Zimmer Biomet$528
  • Bioventus LLC$356
  • Johnson & Johnson$304
  • DJO, LLC$250
  • plus $1K from 15 others

What the payments were for

  • Travel & lodging$3697%
  • Food & beverage$5,05293%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few adult reconstructive orthopaedic surgery providers in New Hampshireto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$421,038
Medicare patients
426
Services billed
10,875

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib96$2,656
Mupirocin83$535
Oxycodone Hcl20$182
Diclofenac Sodium22$180
Amoxicillin131$174
Prednisone54$130
Clindamycin Hcl29$103
Gabapentin17$36
Tramadol Hcl12$31

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Nashua

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →